Heterozygous CENH3 monocots and methods of use thereof for haploid induction and simultaneous genome editing
Pith reviewed 2026-06-25 03:02 UTC · model grok-4.3
The pith
A diploid monocot plant heterozygous for CENH3 induces haploids while carrying CRISPR for simultaneous genome editing.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The paper claims that a diploid monocot haploid inducer plant heterozygous for CENH3, having only two CenH3 alleles with one wildtype and one null, and expressing an exogenous CRISPR nuclease, guide RNA, and donor sequence, can be used for haploid induction and simultaneous genome editing.
What carries the argument
The heterozygous CENH3 state with one null allele that triggers haploid induction while the plant maintains CRISPR components for editing.
If this is right
- The plant can produce haploid progeny that have undergone genome editing at the targeted site.
- Genome editing and haploid induction occur in the same process without separate steps.
- Viable diploid inducer lines can be maintained and propagated.
- Donor sequences can be introduced via homology-directed repair in the haploid induction context.
Where Pith is reading between the lines
- If the mechanism works, it may allow editing of multiple loci by providing multiple guides.
- Such plants could be crossed to other lines to introduce the inducer trait.
- Testing in different monocot species would show if the approach is broadly applicable.
Load-bearing premise
A heterozygous configuration with one null CENH3 allele reliably induces haploids in monocots while supporting CRISPR activity and plant fertility.
What would settle it
Failure to recover haploid progeny or edited plants from crosses using the described heterozygous CENH3 monocot with CRISPR components would falsify the claim.
read the original abstract
1 . A diploid monocot haploid inducer plant heterozygous for centromeric histone 3 (CenH3) comprising diploid plant cells comprising only two CenH3 alleles, wherein one allele encodes wildtype CENH3 protein and the other allele is a null allele, and wherein the diploid plant cells express an exogenous CRISPR-based site-directed nuclease and a guide RNA, and the plant's genome further comprises a donor nucleic acid sequence to be introduced by recombination at a cleavage site induced by the nuclease.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript is a patent claim (abstract/claim 1) for a diploid monocot haploid inducer plant that is heterozygous for centromeric histone 3 (CENH3), possessing one wild-type allele and one null allele. The diploid cells express an exogenous CRISPR-based site-directed nuclease and guide RNA, and the genome includes a donor nucleic acid sequence for recombination at the nuclease-induced cleavage site. The configuration is asserted to enable haploid induction combined with genome editing.
Significance. If the claimed plant configuration were experimentally validated, it could enable simultaneous haploid induction and targeted genome editing in monocot crops, offering a tool for accelerated breeding. The document supplies no data, methods, results, or references to support viability, fertility, haploid induction efficacy, or CRISPR compatibility in monocots, so significance cannot be assessed.
major comments (2)
- [Abstract/Claim 1] Abstract/Claim 1: The central assertion that a heterozygous CENH3 plant (one wild-type, one null allele) induces haploids in monocots while remaining viable and fertile is unsupported by any experimental evidence, methods description, or data within the document. The claim rests entirely on an untested extrapolation from dicot literature.
- [Abstract/Claim 1] Abstract/Claim 1: No validation is provided that the heterozygous state is compatible with simultaneous CRISPR expression and donor recombination without loss of plant viability or fertility, rendering the combined functionality claim load-bearing but unverified.
Simulated Author's Rebuttal
We thank the referee for their review of this patent application. This document is a patent claim rather than an experimental research manuscript, and the claims are presented based on the described configuration and prior art. We respond to the major comments below.
read point-by-point responses
-
Referee: [Abstract/Claim 1] Abstract/Claim 1: The central assertion that a heterozygous CENH3 plant (one wild-type, one null allele) induces haploids in monocots while remaining viable and fertile is unsupported by any experimental evidence, methods description, or data within the document. The claim rests entirely on an untested extrapolation from dicot literature.
Authors: We agree that the patent application contains no experimental data, methods, or results. As a patent document, it describes the claimed plant configuration and its intended utility, drawing on published dicot results for heterozygous CENH3 haploid induction. The inventive aspect is the application to monocots with the added CRISPR components. No changes to the claim are warranted, as this reflects the nature of patent filings. revision: no
-
Referee: [Abstract/Claim 1] Abstract/Claim 1: No validation is provided that the heterozygous state is compatible with simultaneous CRISPR expression and donor recombination without loss of plant viability or fertility, rendering the combined functionality claim load-bearing but unverified.
Authors: We acknowledge that the document provides no experimental validation or data on viability, fertility, or compatibility of the heterozygous CENH3 state with CRISPR expression and donor recombination. The claim describes the integrated configuration for simultaneous haploid induction and genome editing, but we do not provide supporting results within this application. revision: no
- Absence of any experimental evidence or data supporting haploid induction in monocots
- Lack of validation for compatibility of the heterozygous CENH3 configuration with CRISPR and donor DNA without compromising viability or fertility
Circularity Check
No circularity: patent claim contains no derivation chain
full rationale
The document consists solely of a patent claim (Claim 1) that defines a heterozygous CENH3 monocot plant configuration incorporating CRISPR components and a donor sequence. No equations, predictions, fitted parameters, self-citations, or logical derivations are present. The text does not attempt to derive any result from prior inputs or reduce any quantity to itself by construction. This matches the reader's assessment of zero circularity and falls under the default expectation for non-derivational documents such as patents.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.